Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_assertion description "[In this study, we show that overexpression of the oncogenic receptor tyrosine kinase AXL is sufficient to mediate acquired resistance to cetuximab in models of non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), where AXL was overexpressed, activated, and tightly associated with EGFR expression in cells resistant to cetuximab (Ctx(R) cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_assertion evidence source_evidence_literature NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_assertion SIO_000772 25136066 NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_assertion wasDerivedFrom befree-20150227 NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_assertion wasGeneratedBy ECO_0000203 NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP258285.RAR_OArUCa8thwm9BZ5dTzaggPVVRgXpJH9ijrjNDKuQk130_provenance.